FrancophonIA/ELRC3.0 huggingface dataset:
English: According to literature reports, it may be considered that both spermatogenetic and genetic damage in male test is are unlikely at the dose of 1,000 MBq.
Croatian: Plodnost Prema izvješćima iz literature, može se smatrati da pri dozi radioaktivnosti od 1000 MBq vjerojatno neće doći do spermatogenetskog i genetskog oštećenja u testisima muškarca.
English: Cuprymina is only to be used by specialists experienced with in vitro radiolabelling
Croatian: Cupryminu smiju primjenjivati samo specijalisti s iskustvom u in vitro radioobilježavanju.
English: Appropriate aseptic precautions should be taken.
Croatian: Potrebno je poduzeti odgovarajuće mjere kako bi se osigurali aseptički uvjeti.
English: Dispose in accordance with local requirements.
Croatian: Zbrinuti u skladu s nacionalnim propisima
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING TUNGSTEN OR LEAD CONTAINER
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU VOLFRAM ILI OLOVNI SPREMNIK
English: The duration of stopping will depend on the particular radiolabelled medicinal product.
Croatian: Trajanje prekida dojenja će ovisiti o konkretnom radioobilježenom lijeku.
English: Considering that each MBq of Copper-64 causes a dose rate of 9 nSv/h (at a distance of 2 meters) and that the maximum injected activity is of 2,770 MBq, the initial dose rate is 24,930 nSv/h.
Croatian: S obzirom da svaki MBq radioaktivnosti porijeklom od bakra-64 uzrokuje zračenje u dozi od 9 nSv/h (na udaljenosti od 2 metra) i da maksimalna injicirana radioaktivnost iznosi 2770 MBq, početna doza zračenja je 24 930 nSv/h.
English: The activity administered must be such that the resulting radiation dose is as low as reasonably achievable bearing in mind the need to obtain the intended result.
Croatian: Primijenjena radioaktivnost mora biti takva da rezultira razumno niskom dozom zračenja, već prema potrebnoj dozi zračenja za dobivanje željenog rezultata.
English: Many international bodies assessed copper genotoxicity and carcinogenicity concluding that there is no conclusive evidence that copper may be mutagenic or carcinogenic The Scientific Committee on Food of the European Commission (2003) recommend a Dietary Allowances of 0.9 mg copper/day in adult males and females and established a Tolerable Upper Uptake level of 5 mg/day, allowing a huge safety margin in comparison to copper amount administered by Cuprymina.
Croatian: Znanstveni odbor Europske komisije za hranu (2003) preporučuje dopušteni unos bakra prehranom u količini od 0,9 mg/dan za odrasle muškarce i žene, a ustanovljena je podnošljiva gornja razina unosa od 5 mg/dan, dajući široke granice sigurnosti u usporedbi s količinom bakra porijeklom od Cuprymine.
English: Cuprymina is intended for in vitro radiolabelling of medicinal products, which are subsequently administered by the approved route.
Croatian: Cuprymina je namijenjena za in vitro radioobilježavanje lijekova, koji se potom primjenjuju na prethodno odobren način.
English: ANNEX II A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Croatian: UVJETI ILI OGRANIČENJA VEZANI UZ OPSKRBU I PRIMJENU C. OSTALI UVJETI I ZAHTJEVI ZA STAVLJANJE LIJEKA U PROMET
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS TYPE I VIAL LABEL
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE NALJEPNICA BOČICE TIPA 1
English: Storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials.
Croatian: Čuvanje radiofarmaceutika će biti u skladu s nacionalnim propisima za radioaktivne materijale.
English: The possible use of chelating therapies could interfere with the use of Copper-64-labelled medicinal products.
Croatian: Primjena kelirajuće terapije bi mogla ometati primjenu lijekova obilježenih bakrom-64.
English: The quantity of Cuprymina required for radiolabelling and the quantity of Copper-64-labelled medicinal product that is subsequently administered will depend on the medicinal product radiolabelled and its intended use.
Croatian: Količina Cuprymine potrebne za radioobilježavanje i količina lijeka obilježenog bakrom-64 koji se naknadno primjenjuje će ovisiti o radioobilježenom lijeku i njegovoj namjeravanoj primjeni.
English: Radiopharmaceuticals should be received, used and administered only by authorised persons in designated clinical settings.
Croatian: Radiofarmaceutike smiju zaprimati, koristiti i primjenjivati samo ovlaštene osobe u određenim kliničkim ustanovama.
English: Storage of radiopharmaceuticals should be in accordance with national regulation on radioactive materials.
Croatian: Čuvanje radiofarmaceutika treba biti u skladu s nacionalnim propisima za radioaktivni materijal.
English: 48 hours from date and time of End of Synthesis (EOS).
Croatian: ROK VALJANOSTI Rok valjanosti: 48 sati od datuma i vremena kraja sinteze (EOS).
English: ULI wall heart wall kidneys liver lungs muscle ovaries pancreas red marrow 0.00581 0.00565 0.00670 0.0118 0.0242 0.0586 0.198 osteogenic cells skin spleen testes thymus thyroid urinary bladder wall 0.00 uterus effective dose ( Sv/1 GBq administered) adult male adult female 15 years 10 years 5 years 1 years newborn
Croatian: godina godina 5 godina 1 godina novoro đenče nadbubrežne žlijezde 0,00 mozak dojke stijenka žučnog mjehura stijenka donjeg dijela debelog crijeva tanko crijevo stijenka želuca stijenka gornjeg dijela debelog crijeva 0,00 stijenka srca bubrezi jetra pluća mišić jajnici gušterača crvena koštana srž 0,00581 0,00565 0,00670 0,0118 0,0242 0,0586 0,198 osteogene stanice 0,00202 0,00269 0,00263 0,00426 0,00718 0,0172 0,0549 koža slezena testisi timus štitnjača stijenka mokraćnog mjehura maternica efektivna doza (primijenjeno Sv/1 GBq)
English: The volume of one vial ranges from 1 to 3 mL solution (corresponding to 925 to 2,770 MBq at calibration time).
Croatian: Volumen jedne bočice je u rasponu od 1 do 3 ml otopine (što odgovara 925 do 2770 MBq u vrijeme kalibracije).
English: Talk to your nuclear medicine doctor before using the medicine that is radiolabelled with Cuprymina.
Croatian: Obratite se svom liječniku specijalistu nuklearne medicine prije nego uzmete lijek koji se radioaktivno označava Cupryminom.
English: Copper-64 decays also in stable Zinc (64Zn) by emission of β- (39 %).
Croatian: Bakar-64 se također emisijom β- čestica ( 39%) raspada u stabilni cink (64Zn).
English: SPECIAL STORAGE CONDITIONS Store in the original package that provides protection from radiation, according to local regulation.
Croatian: Čuvati u originalnom pakiranju koje pruža zaštitu od zračenja, u skladu s nacionalnim propisima.
English: Marketing Authorisation Holder SPARKLE S.r.l.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet SPARKLE S.r.l.
English: The vials are packed into a tungsten or lead container for protective shielding.
Croatian: Bočice su pakirane u volframski ili olova spremnik radi zaštite.
English: Radiopharmaceuticals should be prepared in a manner which satisfies both radiation safety and pharmaceutical quality requirements.
Croatian: Radiofarmaceutike treba pripremiti na način koji zadovoljava i sigurnosne mjere od zračenja i zahtjeve farmaceutske kakvoće.
English: CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Croatian: D UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU LIJEKA
English: 15 years 10 years 5 years 1 years newborn adrenals brain breasts gallbladder wall
Croatian: odrasli muškarci odrasle žene godina godina 5 godina 1 godina novoro đenče
English: Should you have any further question on the use of Cuprymina, please ask the nuclear medicine doctor who supervises the procedure.
Croatian: Ukoliko imate bilo kakvo pitanje o primjeni Cuprymine, obratite se specijalisti nuklearne medicine koji nadzire postupak.
English: Almost the entire 64CuCl2 rapidly leaves the blood and enters the liver and kidney.
Croatian: CuCl2 brzo prelazi iz krvi u jetru i bubrege.
English: Your nuclear medicine doctor will inform you about the usual duration of the procedure before the administration of the medicine radiolabelled with Cuprymina.
Croatian: Liječnik specijalist nuklearne medicine obavijestit će Vas o uobičajenom trajanju postupka prije primjene lijeka radioobilježenog Cupryminom.
English: Pharmacotherapeutic group: various diagnostic radiopharmaceuticals, ATC code: Not yet assigned
Croatian: Farmakoterapijska skupina: razni dijagnostički radiofarmaceutici, ATK oznaka: nije još dodijeljena Farmakodinamička svojstva lijekova obilježenih bakrom-64 pripremljenih radioobilježavanjem
English: What you need to know before the medicine radiolabelled with Cuprymina is used
Croatian: Što morate znati prije nego se primijeni lijek radioaktivno označen Cupryminom
English: It contains the active substance copper (64Cu) chloride.
Croatian: Ona sadrži djelatnu tvar bakrov (64Cu) klorid.
English: What Cuprymina looks like and contents of the pack Cuprymina is presented as a clear, and colourless solution filled in a 10 mL glass vial.
Croatian: Cuprymina je bistra i bezbojna otopina u staklenoj bočici od 10 ml.
English: Each vial contains an activity ranging from 925 MBq to 2,770 MBq (at calibration time) which corresponds to an amount of 0.25 to 0.75 micrograms of Copper-64.
Croatian: Svaka bočica sadrži aktivnost u rasponu od 925 MBq do 2770 MBq (u vrijeme kalibracije) što odgovara količini od 0,25 do 0,75 mikrograma bakra-64.
English: Administration procedures should be carried out in a way to minimise risk of contamination of the medicinal product and irradiation of the operators.
Croatian: Postupci primjene trebaju se provoditi na način da se rizik od kontaminacije lijeka i rizik od ozračivanja rukovatelja svede na najmanju moguću razinu.
English: The medicinal product must be aseptically withdrawn through the stopper using sterilised single-use needle and syringe after disinfecting the stopper.
Croatian: Nakon dezinfekcije čepa, lijek se mora aseptički izvući kroz čep koristeći steriliziranu iglu i štrcaljku za jednokratnu uporabu.
English: Please refer to the package leaflet of the medicine that is to be radiolabelled with Cuprymina.
Croatian: Molimo pogledajte uputu o lijeku za lijek koji će se radioaktivno označiti Cupryminom.
English: You will be asked to stop breast-feeding if you need to receive a medicine radiolabelled with Cuprymina.
Croatian: Ako dojite Bit će Vam rečeno da prestanete dojiti ako morate primiti lijek radioobilježen Cupryminom.
English: There are strict laws on the use, handling and disposal of radiopharmaceutical products.
Croatian: Kako se primjenjuje lijek radioaktivno označen Cupryminom Postoje strogi zakoni o korištenju, rukovanju i odlaganju pripravaka radiofarmaceutika.
English: There could be effects on your ability to drive and to use machines due to the medicine used in combination with Cuprymina.
Croatian: Mogući su učinci na sposobnost upravljanja vozilima i rada sa strojevima posredovani lijekom koji je radioaktivno označen Cupryminom.
English: Not intended for direct administration to patients.
Croatian: Nije namijenjeno za izravnu primjenu bolesnicima.
English: The medicine radiolabelled with Cuprymina must not be used: - If you are allergic to copper or any of the other ingredients of this medicine listed in section 6.
Croatian: Ako ste alergični na bakar ili bilo koji drugi sastojak ovog lijeka navedenog u dijelu 6.
English: The calibration time is set between the end of the synthesis time and the expiry time.
Croatian: Vrijeme kalibracije je postavljeno između kraja sinteze (EOS) i isteka roka valjanosti.
English: Such information is supplied in the Summary of Product Characteristics/package leaflet of the medicinal product to be radiolabelled.
Croatian: Takve informacije su navedene u Sažetku opisa svojstava lijeka/uputi o lijeku lijeka koji će biti radioobilježen.
English: EXPIRY DATE EXP {DD/MM/YYYY} (hh:mm CET)
Croatian: ROK VALJANOSTI EXP {DD/MM/GGGG} (hh:mm CET) BROJ SERIJE
English: - Established or suspected pregnancy or when pregnancy has not been excluded (see section 4.6).
Croatian: - Ustanovljena trudnoća ili sumnja na trudnoću ili u slučaju kada se trudnoća ne može isključiti
English: The nuclear medicine doctor will inform you if you need to take any special precautions after receiving the medicine radiolabelled with Cuprymina.
Croatian: Nakon primjene lijeka radioobilježenog Cupryminom Specijalist nuklearne medicine će Vas obavijestiti ako je potrebno poduzeti bilo kakve posebne mjere predostrožnosti nakon primanja lijeka radioobilježenog Cupryminom.
English: Cuprymina is not to be administered directly to the patient but must be used for the radiolabelling of carrier molecules, such as monoclonal antibodies, peptides or other substrates.
Croatian: 4.4 Posebna upozorenja i mjere opreza pri uporabi Opravdanost primjene na osnovi individualne procjene koristi/rizika Cuprymina se ne smije primijeniti izravno bolesniku, nego se mora koristiti za radioobilježavanje molekula nosača, kao što su monoklonska protutijela, peptidi ili drugi supstrati.
English: It is not intended for direct use in patients.
Croatian: Nije namijenjen za izravnu primjenu bolesnicima
English: Relevant data is included in the Summary of Product Characteristics of the labelled medicinal products.
Croatian: Sažetku opisa svojstava obilježenih lijekova.
English: The following preparations must be available in medical institutions, which use Cuprymina for labelling of carrier molecules: - Ca-DTPA (Trisodium calcium diethylenetriaminepentaacetate) or - Ca-EDTA (Calcium disodium ethylenediaminetetraacetate)
Croatian: Ca-DTPA (Trinatrijev kalcij dietilenetriaminpentaacetat) ili Ca-EDTA (Kalcijev dinatrij etilenediamintetraacetat)
English: Store in the original package that provides protection from radiation.
Croatian: Cuprymina će se čuvati u originalnom pakiranju koje pruža zaštitu od zračenja.
English: Information on radiation dosimetry of each different medicinal product following administration of the radiolabelled preparation is available in the Summary of Product Characteristics/package leaflet of the particular medicinal product to be radiolabelled.
Croatian: Informacija o dozimetriji zračenja za svaki pojedini lijek nakon primjene radioaktivno označenog lijeka dostupna je u Sažetku opisa svojstava lijeka/uputu o lijeku određenog lijeka koji će biti radioaktivno označen.
English: Adverse reactions following the intravenous administration of Copper-64-labelled medicinal products prepared by radiolabelling with Cuprymina, will be dependent on the specific medicinal product being used.
Croatian: Nuspojave nakon intravenske primjene lijekova obilježenih bakrom-64 pripravljenih radioobilježavanjem Cupryminom, ovisit će o konkretnom lijeku koji se koristi.
English: Further information concerning the use of Copper-64-labelled medicinal products in pregnancy and breast-feeding is specified in the Summary of Product Characteristics of the medicinal product to be radiolabelled.
Croatian: Dodatne informacije o primjeni lijekova obilježenih bakrom-64 u trudnoći i tijekom dojenja su navedene u Sažetku opisa svojstava lijeka koji će biti radioobilježen.
English: For more information, refer to the package leaflet of the particular medicine to be radiolabelled.
Croatian: Za više informacija, pogledajte uputu o lijeku za pojedini lijek koji će biti radioobilježen.
English: Località Cavallino 62010 Montecosaro (MC) - Italy
Croatian: Località Cavallino 62010 Montecosaro (MC) - Italija
English: Activity: {Y}________MBq Cal.: {DD/MM/YYYY} 01h00 a.m. CET
Croatian: Kal: {DD/MM/GGGG} 01h00 CET
English: You must inform the nuclear medicine doctor before the administration of medicines radiolabelled with Cuprymina if there is a possibility you might be pregnant, if you have missed your period or if you are breast-feeding.
Croatian: Cupryminom ako postoji mogućnost da biste mogli biti trudni, ako Vam je izostala mjesečnica ili ako dojite.
English: The toxicological properties of Copper-64-labelled medicinal products prepared by radiolabelling with Cuprymina prior to administration will be dependent on the nature of the medicinal product to be radiolabelled.
Croatian: Toksikološka svojstva lijekova obilježenih bakrom-64 pripremljenih radioobilježavanjem Cupryminom prije njegove primjene ovisit će o prirodi lijeka koji će biti radioobilježen.
English: Loc. Cavallino
Croatian: Località Cavallino,
English: NAME OF THE MEDICINAL PRODUCT Cuprymina 925 MBq/mL radiopharmaceutical precursor, solution
Croatian: NAZIV LIJEKA Cuprymina 925 MBq/ml radiofarmaceutski prekursor, otopina
English: Cuprymina is a radiopharmaceutical precursor.
Croatian: 4.1 Terapijske indikacije Cuprymina je radiofarmaceutski prekursor.
English: NAME OF THE MEDICINAL PRODUCT Cuprymina 925 MBq/mL radiopharmaceutical precursor, solution.
Croatian: NAZIV LIJEKA Cuprymina 925 MBq/ml radiofarmaceutski prekursor, otopina.
English: One vial contains from 925 to 2,770 MBq (corresponding to 0.250.75 micrograms of copper-64).
Croatian: Jedna bočica sadrži radioaktivnost u rasponu od 925 MBq do 2770 MBq što odgovara količini od 0,25-0,75 mikrograma bakra-64. (MBq: megaBekerel, Bekerel je mjerna jedinica za radioaktivnost)
English: Each mL of solution contains 925 MBq at calibration time (01h00 a.m. CET Central European Time), corresponding to at least 0.25 micrograms of copper-64.
Croatian: Svaki ml otopine sadrži 925 MBq bakrovog (64Cu) klorida u vrijeme kalibracije (01h00 po srednje europskom vremenu [CET]), što odgovara najmanje 0,25 mikrograma bakra-64.
English: GENERAL CLASSIFICATION FOR SUPPLY Medicinal product subjects to medical prescription.
Croatian: 14. NAČIN IZDAVANJA LIJEKA Lijek se izdaje na recept.
English: For information on contraindications to particular Copper-64-labelled medicinal products prepared by radiolabelling with Cuprymina refer to the Summary of Product Characteristics/package leaflet of each particular medicinal product to be radiolabelled.
Croatian: Za više informacija o kontraindikacijama za pojedine lijekove obilježene bakrom-64 pripravljene radioobilježavanjem Cupryminom pogledajte Sažetak opisa svojstava lijeka/uputu o svakom pojedinom lijeku koji treba biti radioobilježen.
English: Radiopharmaceuticals should be prepared by the user in a manner which satisfies both radiation safety and pharmaceutical quality requirements.
Croatian: Način na koji ovlaštena osoba pripravlja radiofarmaceutik treba zadovoljavati i mjere zaštite od zračenja i zahtjeve u pogledu farmaceutske kvalitete.
English: For information concerning special warnings and special precautions for use of Copper-64-labelled medicinal products refer to the Summary of Product Characteristics/package leaflet of the medicinal product to be radiolabelled.
Croatian: Za informacije o posebnim upozorenjima i posebnim mjerama opreza pri uporabi lijekova obilježenih bakrom-64 pogledajte Sažetak opisa svojstava lijeka/uputu o specifičnom lijeku koji će biti radioobilježen.
English: If you get any side effects, talk to your nuclear medicine doctor.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti svog liječnika, specijalistu nuklearne medicine.
English: The dosimetry table below is presented in order to evaluate the contribution of non-conjugated Copper64 to the radiation dose following the administration of Copper-64-labelled medicinal product or resulting from an accidental intravenous injection of Cuprymina.
Croatian: 64 dozi zračenja nakon primjene lijeka označenog bakrom-64 ili nakon nehotičnog intravenskog injiciranja Cuprymine.
English: How the medicine radiolabelled with Cuprymina is used
Croatian: Ostali lijekovi i lijekovi radioobilježeni Cupryminom
English: Effects on ability to drive and to use machines following treatment by Copper-64-labelled medicinal products is specified in the Summary of Product Characteristics/package leaflet of the particular medicinal product to be radiolabelled.
Croatian: 4.7 Utjecaj na sposobnost upravljanja vozilima i rada sa strojevima Utjecaj lijekova obilježenih bakrom-64 na sposobnost upravljanja vozilima i rada sa strojevima nakon terapije je naveden u Sažetku opisa svojstava lijeka/uputu o konkretnom lijeku koji treba biti radioobilježen.
English: For information concerning interactions associated with the use of Copper-64-labelled medicinal products refer to the Summary of Product Characteristics/package leaflet of the radiolabelled medicinal product.
Croatian: Za informacije o interakcijama povezanim s korištenjem lijekova obilježenih bakrom-64 pogledajte Sažetak opisa svojstava lijeka/uputu o radioobilježenom lijeku.
English: IT-62010 MONTECOSARO (MC) Italy
Croatian: IT-62010 MONTECOSARO (MC) Italija
English: Cuprymina should be received, used and administered only by authorised persons in designated clinical settings.
Croatian: Samo ovlaštene osobe smiju zaprimati, koristiti i primjenjivati Cupryminu u određenim kliničkim uvjetima.
English: 62010 Montecosaro (MC) - Italy
Croatian: 62010 Montecosaro (MC) - Italija
English: Do not use this medicine after the expiry date and time which are stated on the label after EXP. Cuprymina will be stored in the original package that provides protection from radiation.
Croatian: Cuprymina se ne smije koristiti nakon isteka datuma i vremena navedenog na naljepnici nakon kratice EXP za rok valjanosti.
English: The radiation dose received by the various organs following intravenous administration of a Copper-64labelled medicinal product is dependent on the specific molecule being radiolabelled.
Croatian: Doza zračenja koju primaju različiti organi nakon intravenske primjene lijeka označenog bakrom-64
English: Cuprymina 925 MBq/mL radiopharmaceutical precursor, solution Copper (64Cu) chloride
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Cuprymina 925 MBq / ml radiofarmaceutski prekursor, otopina. bakrov (64Cu) klorid
English: 62010 Montecosaro (MC) Italy
Croatian: 62010 Montecosaro (MC) Italija
English: The presence of free copper (64Cu) chloride in the body after an inadvertent administration of
Croatian: Prisutnost slobodnog bakrovog (64Cu) klorida u organizmu nakon slučajne primjene Cuprymine će dovesti do povećane hepatotoksičnosti.
English: Fertility
Croatian: Cavallino
English: Refer to the Summary of Product Characteristics/package leaflet of the particular medicinal product to be radiolabelled.
Croatian: Pogledajte Sažetak opisa svojstava lijeka/uputu o lijeku za specifični lijek koji treba biti radioobilježen.
English: For more information concerning paediatric use of Copper-64-labelled medicinal products refer to the Summary of Product Characteristics/package leaflet of the radiolabelled medicinal product.
Croatian: Za više informacija u vezi primjene radiofarmaceutskih proizvoda obilježenih bakrom-64 u pedijatriji pogledajte Sažetak opisa svojstava lijeka/uputu o lijeku za radioobilježeni lijek.
English: The surface dose
Croatian: PRIMJENU LIJEKA
English: Copper (64Cu) chloride
Croatian: - Djelatna tvar je bakrov (64Cu) klorid.
English: Further information concerning the effect on fertility of the use of Copper-64-labelled medicinal products is specified in the Summary of Product Characteristics of the medicinal product to be radiolabelled.
Croatian: Dodatne informacije o učinku primjene lijekova obilježenih bakrom-64 na plodnost su navedene u
English: What Cuprymina is and what it is used for What you need to know before the medicine radiolabelled with Cuprymina is used How the medicine radiolabelled with Cuprymina is used Possible side effects
Croatian: Što morate znati prije nego se primjeni lijek radioaktivno označen Cupryminom Lijek radioaktivno označen Cupryminom ne smije se koristiti:
English: (MBq: mega Becquerel, Becquerel is the unit in which radioactivity is measured) - The other ingredients are hydrochloric acid (0.1 N) and water for injections.
Croatian: - Ostali sastojci su kloridna kiselina (0,1 M) i voda za injekcije.
English: SPARKLE S.r.l
Croatian: ACOM S.r.l. SPARKLE S.r.l
English: - if you drink alcohol excessively (either every day or only from time to time).
Croatian: - ako pijete pretjerane količine alkohola (svaki dan ili samo s vremena na vrijeme).